Commerzbanks, Fate

Commerzbank's Fate Hangs on UniCredit's Next Move as Regulators Circle

Published on 07/08/2026 at 06:32 | Redaktion boerse-global.de

UniCredit's exchange offer for Commerzbank yields a complex stake built on derivatives; political and regulatory hurdles, including ECB review, delay any control while Commerzbank stock trades near highs.

UniCredit's Commerzbank Offer Tally: Near-40% Stake May Not Mean Control
Commerzbank Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

All eyes are on Milan today as UniCredit reveals the final tally of its exchange offer for Commerzbank shares. The extended deadline for shareholders expired on July 3, but the numbers due out this Wednesday will determine whether the Italian lender's carefully constructed near-40% stake translates into actual control — or remains a paper tiger.

The stock itself, changing hands at around €38.20, is trading just shy of its 52-week high of €38.85, a level that reflects the market's lingering bet on a premium. Yet beneath the surface, the battle for Germany's second-biggest private bank has become a labyrinth of legal complaints, regulatory hurdles, and political opposition.

A Stake Built on Technicalities

UniCredit's holding of roughly 40% includes a significant chunk of derivative instruments, meaning the actual economic exposure is less straightforward than the headline figure. More importantly, the vast majority of shares tendered came from banks and connected parties, not retail or institutional investors. In the secondary acceptance period, independent investors contributed a mere 1.3% of the total, according to preliminary reports. Private individuals barely sold any stock at all.

This distribution matters because it underpins the Commerzbank board's argument for continued independence. With the German government still holding a double-digit stake of around 12%, and the finance agency openly rejecting UniCredit's approach as both aggressive and lacking a premium, the political resistance is formidable. Commerzbank has gone a step further by lodging a formal complaint with BaFin, accusing UniCredit of providing misleading information about the origin of its shareholdings.

Should investors sell immediately? Or is it worth buying Commerzbank?

The EZB's 90-Day Clock

Even if today's figures confirm a majority economic stake, UniCredit is walking a tightrope. The European Central Bank has 90 days to review any move past critical voting thresholds. Until that review is complete, the Italians cannot push for board changes without risking a forced full consolidation — a prospect that would hammer their profitability.

This regulatory limbo explains why UniCredit has publicly delayed any aggressive governance actions. The bank itself expects the acquisition process to drag on until 2027, pending a slew of other approvals. For Commerzbank's management, every month of delay is a month to prove that their standalone strategy, dubbed "Momentum 2030", can deliver.

Bullish Signs from the Trenches

Commerzbank's recent performance gives the board plenty of ammunition. The stock has gained roughly 28% over the past twelve months. The relative strength index sits at a comfortable 61, well short of overbought territory, and the share price trades 4% above its 50-day moving average of €36.74. The distance to the 200-day line at €34.31 is a healthy 11%.

Under CEO Bettina Orlopp, the bank is targeting a return on tangible equity above 20% by the end of the decade. The dividend for last year came in at €1.10 per share, and between 2025 and 2027 management plans to return nearly all net profit to shareholders. Such a generous payout policy acts as a powerful magnet for long-term investors and raises the opportunity cost of accepting UniCredit's paper offer — which currently values each Commerzbank share below the market price.

The Downside That Lurks

Yet the biggest danger for the stock is that the entire takeover premium evaporates. If today's acceptance figures reveal a material number of independent shareholders deciding to tender, the market could reprice Commerzbank purely on fundamentals, triggering profit-taking. Implied annual volatility of nearly 20% already points to considerable nervousness.

Commerzbank at a turning point? This analysis reveals what investors need to know now.

A decisive rejection by the EZB would plunge the situation into months of legal uncertainty. In that scenario, a test of the 200-day moving average at €34.31 becomes a realistic downside target. A surprise move by UniCredit to exercise its voting power early would create even more regulatory chaos, potentially sending the stock spiralling toward the 50-day line.

What Comes Next

For now, the €38 level is the key support to watch. As long as the stock holds above it, the chart remains constructive. A clean break above €38.85 would open the door to fresh all-time highs. Conversely, a close below the 50-day line at €36.73 would signal the start of a deeper consolidation.

Today's announcement is the immediate catalyst, but the calendar is already set for the next major event: Commerzbank's second-quarter earnings on August 6, 2026. In the meantime, every signal from the ECB — and every move by UniCredit — will be scrutinised for clues about whether this long-running takeover saga ends with a deal or a standoff.

Ad

Commerzbank Stock: New Analysis - 8 July

Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Commerzbank analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE000CBK1001 | COMMERZBANKS | boerse | 69719530 |